Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Newborn screening study aims to catch rare diseases at birth

NCT ID NCT03655223

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study offers voluntary screening for newborns in North Carolina to detect a wide range of rare health conditions early. Using a small blood sample already collected at birth, the program tests for dozens of disorders, including spinal muscular atrophy, cystic fibrosis, and many others. The goal is to identify affected infants before symptoms appear, allowing for prompt treatment and support. Researchers also study the impact of screening on families and evaluate the program's effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this screening program could enable earlier diagnosis and treatment for newborns with rare conditions, potentially improving their health and development.
What could go wrong
This is an observational screening study, not a treatment trial. Most newborns will screen negative, and positive results may cause anxiety. The long-term benefits of early diagnosis are still being evaluated.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 30,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2018

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Newborns born in North or South Carolina who are less than 31 days old

Ages

1 day to 31 days

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Newborn has newborn screening in North Carolina * Newborn lives in North Carolina or South Carolina * Newborn is less than 31 days old * Person giving consent must have legal custody of the newborn. When the mother retains custody, they must be the person to give consent. * Person giving consent must be able to interact with the online permission portal (available in English and Spanish) and give permission online Exclusion Criteria: * A newborn screening (NBS) sample is unavailable for the newborn * Insufficient NBS sample remains to conduct the screening

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for 17 alpha-hydroxylase deficiency are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

3-hydroxy-3-methylglutaric aciduria 3-hydroxyacyl-CoA dehydrogenase deficiency 3-methylcrotonyl-CoA carboxylase 1 deficiency 3-methylcrotonyl-CoA carboxylase 2 deficiency 3-phosphoglycerate dehydrogenase deficiency acrodermatitis enteropathica adenine phosphoribosyltransferase deficiency Adrenal hyperplasia, congenital, type 5 AGAT deficiency Angelman syndrome Aortic Stenosis, Supravalvular apparent mineralocorticoid excess arginase deficiency argininosuccinic aciduria autosomal recessive Alport syndrome autosomal recessive nonsyndromic hearing loss 5 Barth syndrome beta thalassemia beta-ketothiolase deficiency biotin-responsive basal ganglia disease biotinidase deficiency Canavan disease carbamoyl phosphate synthetase I deficiency disease carnitine palmitoyl transferase 1A deficiency carnitine palmitoyltransferase II deficiency carnitine-acylcarnitine translocase deficiency central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease cerebrotendinous xanthomatosis chronic granulomatous disease citrullinemia citrullinemia type I combined immunodeficiency due to ZAP70 deficiency congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency congenital bile acid synthesis defect 1 congenital bile acid synthesis defect 2 Congenital Hyperinsulinism congenital hypothyroidism congenital isolated adrenocorticotropic hormone deficiency congenital lipoid adrenal hyperplasia due to STAR deficency congenital secretory chloride diarrhea 1 creatine transporter deficiency cystic fibrosis cystinosis developmental and epileptic encephalopathy, 2 diabetes mellitus Diabetes Mellitus, Permanent Neonatal, With Neurologic Features dihydropteridine reductase deficiency disease dopa-responsive dystonia due to sepiapterin reductase deficiency Dravet syndrome Duchenne muscular dystrophy encephalopathy due to GLUT1 deficiency Epilepsies, Myoclonic epilepsy epilepsy, early-onset, vitamin B6-dependent factor VII deficiency factor X deficiency familial isolated deficiency of vitamin E familial thyroid dyshormonogenesis fragile X syndrome Fructose Intolerance fructose-1,6-bisphosphatase deficiency Fructose-1,6-Diphosphatase Deficiency G6PD deficiency galactokinase deficiency galactosemia glutaryl-CoA dehydrogenase deficiency glutathione synthetase deficiency with 5-oxoprolinuria glycogen storage disease I glycogen storage disease Ib Glycogen Storage Disease IC glycogen storage disease II glycogen storage disease IXa1 glycogen storage disease IXa2 glycogen storage disease IXb glycogen storage disease IXc Glycogen Storage Disease Type II Glycogen Storage Disease, Type IXA2 GTP cyclohydrolase I deficiency guanidinoacetate methyltransferase deficiency hearing loss, autosomal recessive hemophilia A hemophilia B hereditary fructose intolerance hereditary hypophosphatemic rickets hereditary intrinsic factor deficiency hereditary nephritis Hermansky-Pudlak syndrome Hermansky-Pudlak syndrome 1 Hermansky-Pudlak syndrome 4 holocarboxylase synthetase deficiency homocystinuria homocystinuria due to methylene tetrahydrofolate reductase deficiency hyperammonemia due to N-acetylglutamate synthase deficiency hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency hyperinsulinemic hypoglycemia, familial, 1 hyperinsulinemic hypoglycemia, familial, 2 hyperinsulinism-hyperammonemia syndrome Hyperphenylalaninemia, BH4-Deficient, B hypophosphatasia hypothyroidism due to TSH receptor mutations inherited glutathione synthetase deficiency isolated thyroid-stimulating hormone deficiency isovaleric acidemia Jervell and Lange-Nielsen syndrome Jervell and Lange-Nielsen syndrome 1 Jervell and Lange-Nielsen syndrome 2 Krabbe disease Leber congenital amaurosis 2 Liddle syndrome long chain 3-hydroxyacyl-CoA dehydrogenase deficiency lysosomal acid lipase deficiency maple syrup urine disease type 1A maple syrup urine disease type 1B maple syrup urine disease type 2 Maple syrup urine disease, type 1A Maple syrup urine disease, type 1B Maple syrup urine disease, type 2 maturity-onset diabetes of the young type 4 medium chain acyl-CoA dehydrogenase deficiency Menkes disease metachromatic leukodystrophy methylcobalamin deficiency type cblE methylcobalamin deficiency type cblG methylmalonic aciduria and homocystinuria methylmalonic aciduria and homocystinuria type cblC methylmalonic aciduria and homocystinuria type cblD Methylmalonic aciduria cblA type Methylmalonic aciduria cblB type methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency methylmalonic aciduria, cblA type methylmalonic aciduria, cblB type mitochondrial trifunctional protein deficiency Mowat-Wilson syndrome MPI-congenital disorder of glycosylation Mucopolysaccharidosis I Mucopolysaccharidosis III Mucopolysaccharidosis IV mucopolysaccharidosis type 1 mucopolysaccharidosis type 2 mucopolysaccharidosis type 3 mucopolysaccharidosis type 3A mucopolysaccharidosis type 4A mucopolysaccharidosis type 6 mucopolysaccharidosis type 7 multiple endocrine neoplasia type 2B neonatal severe primary hyperparathyroidism Niemann-Pick disease type A Niemann-Pick disease type C Niemann-Pick disease, type C1 Niemann-Pick disease, type C2 ornithine aminotransferase deficiency ornithine carbamoyltransferase deficiency ornithine translocase deficiency pancreatic agenesis 1 permanent neonatal diabetes mellitus pernicious anemia Peroxisomal Disorders peroxisome biogenesis disorder 1B phenylketonuria Pitt-Hopkins syndrome pituitary hormone deficiency, combined, 1 post-traumatic stress disorder Prader-Willi syndrome primary hyperoxaluria type 1 primary hyperoxaluria type 2 primary hyperoxaluria type 3 propionic acidemia pseudohypoaldosteronism pseudohypoaldosteronism type 1 pyridoxal phosphate-responsive seizures pyridoxine-dependent epilepsy retinoblastoma Rett syndrome riboflavin transporter deficiency severe combined immunodeficiency due to DCLRE1C deficiency severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive sickle cell disease Smith-Lemli-Opitz syndrome spinal muscular atrophy spondylocostal dysostosis Stickler syndrome type 1 Stickler syndrome type 2 sulfite oxidase deficiency due to molybdenum cofactor deficiency type A supravalvular aortic stenosis T-B+ severe combined immunodeficiency due to gamma chain deficiency T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency T-B+ severe combined immunodeficiency due to JAK3 deficiency TH-deficient dopa-responsive dystonia thyroid dyshormonogenesis 1 thyroid dyshormonogenesis 2A thyroid dyshormonogenesis 3 thyroid dyshormonogenesis 5 thyroid dyshormonogenesis 6 transcobalamin II deficiency transient neonatal diabetes mellitus tuberous sclerosis 1 tuberous sclerosis 2 tyrosine hydroxylase deficiency tyrosinemia tyrosinemia type I Usher syndrome type 1B Usher syndrome type 1C Usher syndrome type 1D Usher syndrome type 1F Usher syndrome type 1G Usher syndrome, type 1C Usher syndrome, type 1F very long chain acyl-CoA dehydrogenase deficiency VLCAD deficiency von Willebrand disease 3 Waardenburg syndrome Waardenburg syndrome type 1 Waardenburg syndrome type 2 Waardenburg syndrome type 2A Waardenburg syndrome type 2E Wilson disease Wolman disease X-linked Alport syndrome X-Linked Combined Immunodeficiency Diseases X-linked hypophosphatemic rickets

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

17 alpha-hydroxylase deficiency 3-hydroxy-3-methylglutaric aciduria 3-hydroxyacyl-coa dehydrogenase deficiency 3-methylcrotonyl coa carboxylase 1 deficiency 3-methylcrotonyl coa carboxylase 2 deficiency 3-phosphoglycerate dehydrogenase deficiency Acrodermatitis enteropathica Adenine phosphoribosyltransferase deficiency Adrenocorticotropic hormone deficiency Adrenoleukodystrophy, neonatal Agat deficiency Alport syndrome, autosomal recessive Alport syndrome, X-linked Angelman syndrome Apparent mineralocorticoid excess Argininosuccinic aciduria Ataxia with isolated vitamin E deficiency Autosomal recessive nonsyndromic hearing loss Barth syndrome Beta-ketothiolase deficiency Beta-thalassemia Biotin-responsive basal ganglia disease Biotinidase deficiency Canavan disease Carbamoyl phosphate synthetase I deficiency disease Carbonic anhydrase va deficiency Carnitine palmitoyl transferase 1A deficiency Carnitine palmitoyltransferase ii deficiency Carnitine-acylcarnitine translocase deficiency CBAS1 CBLF Central hypoventilation syndrome with or without Hirschsprung disease Cerebrotendinous xanthomatoses Chronic granulomatous disease Citrullinemia, type I Combined immunodeficiency due to ZAP70 deficiency Congenital bile acid synthesis defect type 2 Congenital disorder of glycosylation type 1B Congenital hypothyroidism Congenital isolated thyroid stimulating hormone deficiency Congenital lipoid adrenal hyperplasia due to star deficiency Creatine transporter deficiency Cystic fibrosis Cystinosis Developmental and epileptic encephalopathy 2 Diabetes mellitus Diabetes mellitus, permanent neonatal Diabetes mellitus, permanent neonatal, with neurologic features DIAR1 Dihydropteridine reductase deficiency Dravet syndrome Duchenne muscular dystrophy Epilepsy, early-onset, vitamin B6-dependent Factor vii deficiency Factor X deficiency Fragile X - premutation Fragile X syndrome Fructose 1,6 bisphosphatase deficiency G6PD deficiency Galactokinase deficiency Galactosemias Glucose transporter type 1 deficiency syndrome Glutaryl-coa dehydrogenase deficiency Glutathione synthetase deficiency Glycogen storage disease ic Glycogen storage disease ii Glycogen storage disease ixb Glycogen storage disease ixc Glycogen storage disease type I Glycogen storage disease type IB Glycogen storage disease type IXA1 Glycogen storage disease, type IXA2 GSD1C GTP cyclohydrolase I deficiency Guanidinoacetate methyltransferase deficiency Hemophilia A Hemophilia B Hereditary fructose intolerance Hereditary hypophosphatemic rickets Hermansky-Pudlak syndrome 1 Hermansky-Pudlak syndrome 4 Holocarboxylase synthetase deficiency Homocystinuria HSDB Hyperargininemia Hyperinsulinemic hypoglycemia, familial 1 Hyperinsulinemic hypoglycemia, familial, 2 Hyperinsulinism-hyperammonemia syndrome Hypophosphatasia Hypothyroidism due to TSH receptor mutations Intrinsic factor deficiency Isovaleric acidemia Jervell and lange-nielsen syndrome 1 Jervell and lange-nielsen syndrome 2 Krabbe disease Leber congenital amaurosis 2 Liddle syndrome Long-chain 3-hydroxyacyl-coa dehydrogenase deficiency Lysosomal acid lipase deficiency MAHCD Maple syrup urine disease, type 1A Maple syrup urine disease, type 1B Maple syrup urine disease, type 2 Medium-chain acyl-coa dehydrogenase deficiency Menkes disease Metachromatic leukodystrophy Methylcobalamin deficiency type CBL G (disorder) Methylcobalamin deficiency type cble Methylmalonic aciduria and homocystinuria type CBLC Methylmalonic aciduria cbla type Methylmalonic aciduria CBLB type Methylmalonic aciduria due to methylmalonyl-coa mutase deficiency Mitochondrial trifunctional protein deficiency Molybdenum cofactor deficiency, type A MOWS MTHFR deficiency Mucopolysaccharidosis type 1 Mucopolysaccharidosis type 2 Mucopolysaccharidosis type 3 A Mucopolysaccharidosis type 6 Mucopolysaccharidosis type 7 Mucopolysaccharidosis type IV A Multiple endocrine neoplasia type 2B N-acetylglutamate synthase deficiency Neonatal severe primary hyperparathyroidism Niemann-Pick disease type A Niemann-Pick disease type C1 Niemann-Pick disease type C2 Ornithine aminotransferase deficiency Ornithine transcarbamylase deficiency Ornithine translocase deficiency Pancreatic agenesis 1 Permanent neonatal diabetes mellitus Phenylketonurias Pitt hopkins syndrome Pituitary hormone deficiency, combined, 1 Prader-Willi syndrome Primary hyperoxaluria type 1 Primary hyperoxaluria type 2 Primary hyperoxaluria type 3 Propionic acidemia Pseudohypoaldosteronism, type I PTSD Pyridoxal phosphate-responsive seizures Pyridoxine-dependent epilepsy Retinoblastoma Rett syndrome Riboflavin transporter deficiency SCD Segawa syndrome, autosomal recessive Severe combined immunodeficiency due to adenosine deaminase deficiency Severe combined immunodeficiency due to DCLRE1C deficiency Severe combined immunodeficiency due to il-7RALPHA deficiency Severe combined immunodeficiency due to RAG1 deficiency Severe combined immunodeficiency due to RAG2 deficiency Severe combined immunodeficiency T-cell negative B-cell positive due to janus kinase-3 deficiency (disorder) Severe combined immunodeficiency, X linked Sickle cell disease Smith-Lemli-Opitz syndrome Spinal muscular atrophy SRD Stickler syndrome type 1 Stickler syndrome type 2 Supravalvar aortic stenosis Thyroid dyshormonogenesis 1 Thyroid dyshormonogenesis 2A Thyroid dyshormonogenesis 3 Thyroid dyshormonogenesis 5 Thyroid dyshormonogenesis 6 Transcobalamin ii deficiency Transient neonatal diabetes mellitus Tuberous sclerosis 1 Tuberous sclerosis 2 Tyrosinemia, type I Usher syndrome type 1C Usher syndrome type 1D/F digenic (diagnosis) Usher syndrome type 1G (diagnosis) Usher syndrome, type 1B Usher syndrome, type 1F Very long chain acyl coa dehydrogenase deficiency Von Willebrand disease, type 3 Waardenburg syndrome type 1 Waardenburg syndrome type 2A Waardenburg syndrome, type 2E Wilson disease

Contacts and locations

Locations

  • RTI International

    Research Triangle Park, North Carolina, 27709, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.